General MedicationsOPHTHALMICGeneric

BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE

BACITRACIN; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE

Standard Dose

400 UNITS/GM;1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE is listed in Drugs@FDA under application 060731 (ANDA).

Marketing status: Discontinued Active ingredient BACITRACIN; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE Form and strength OINTMENT;OPHTHALMIC - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM Sponsor ALTANA Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE is listed in Drugs@FDA under application 060731 (ANDA). Marketing status: Discontinued Active ingredient BACITRACIN; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE Form and strength OINTMENT;OPHTHALMIC - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM Sponsor ALTANA Submission history See approval history documents.

Monitoring

• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.